Frances M Richards

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 7

Top Venues

Cancer research

Molecular cancer therapeutics

Proceedings of the National Academy of Sciences of the United States of America

Nature communications

University of Cambridge

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Cambridge Dec 01 2008

United Kingdom

Senior Research Associate/ Lab head :: Cancer Research UK Cambridge Institute

DanioLabs Ltd/ Summit plc Aug 01 2002 - Oct 31 2008

United Kingdom

Team Leader/Project Manager

University of Birmingham Sep 01 1996 - Jul 31 2002

United Kingdom

Lecturer then Senior Lecturer :: Human Molecular Genetics

Publications

Marina Roy-Luzarraga, Louise E Reynolds, Beatriz de Luxán-Delgado, Oscar Maiques, Laura Wisniewski, Emma Newport, Vinothini Rajeeve, Rebecca J G Drake, Jesús Gómez-Escudero, Frances M Richards, Céline Weller, Christof Dormann, Ya-Ming Meng, Peter B Vermeulen, Dieter Saur, Victoria Sanz-Moreno, Ping-Pui Wong, Cyrill Géraud, Pedro Rodriguez Cutillas, Kairbaan M Hodivala-Dilke
Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment. Cancer research 82 (10) (2022)
Andrea Bistrović Popov, Francesca Melle, Emily Linnane, Cristina González-López, Ishtiaq Ahmed, Badri Parshad, Christoph O Franck, Hassan Rahmoune, Frances M Richards, Daniel Muñoz-Espín, Duncan I Jodrell, David Fairen-Jimenez, Ljiljana Fruk
Size-tuneable and immunocompatible polymer nanocarriers for drug delivery in pancreatic cancer. Nanoscale 14 (17) (2022)
Dandan Li, Nicholas Schaub, Theresa M Guerin, Tashinga E Bapiro, Frances M Richards, Vicky Chen, Keyur Talsania, Parimal Kumar, Debra J Gilbert, Jerome J Schlomer, Seong-Jin Kim, Rebecca Sorber, Yaroslav Teper, Wendy Bautista, Claudia Palena, Chan-Young Ock, Duncan Ian Jodrell, Nathan M Pate, Monika Mehta, Yongmei Zhao, Serguei Kozlov, Rushikesh Sable
T Cell-Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Cancer. Molecular cancer therapeutics 20 (10) (2021)
Daniele Biasci, Martin Smoragiewicz, Claire M Connell, Zhikai Wang, Ya Gao, James E D Thaventhiran, Bristi Basu, Lukasz Magiera, T Isaac Johnson, Lisa Bax, Aarthi Gopinathan, Christopher Isherwood, Ferdia A Gallagher, Maria Pawula, Irena Hudecova, Davina Gale, Nitzan Rosenfeld, Petros Barmpounakis, Elizabeta Cristina Popa, Rebecca Brais, Edmund Godfrey, Fraz Mir, Frances M Richards, Douglas T Fearon, Tobias Janowitz, Duncan I Jodrell
CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proceedings of the National Academy of Sciences of the United States of America 117 (46) (2020)
Matthew J Sale, Emma Minihane, Noel R Monks, Rebecca Gilley, Frances M Richards, Kevin P Schifferli, Courtney L Andersen, Emma J Davies, Mario Aladren Vicente, Eiko Ozono, Aleksandra Markovets, Jonathan R Dry, Lisa Drew, Vikki Flemington, Theresa Proia, Duncan Ian Jodrell, Paul D Smith, Simon J Cook
Targeting melanoma's MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors. Nature communications 10 (1) (2019)
Yann Wallez, Charles R Dunlop, Timothy Isaac Johnson, Siang-Boon Koh, Chiara Fornari, James W T Yates, Sandra Bernaldo de Quirós Fernández, Alan Lau, Frances M Richards, Duncan I Jodrell
The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression. Molecular cancer therapeutics 17 (8) (2018)
Siang-Boon Koh, Yann Wallez, Charles R Dunlop, Sandra Bernaldo de Quirós Fernández, Tashinga E Bapiro, Frances M Richards, Duncan I Jodrell
Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine. Cancer research 78 (11) (2018)

Frances M Richards.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Frances M Richards